PCR Assay Validation Using Melt-Shifted Positive Controls
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing PCR-based diagnostic assays face challenges with false positives due to contamination from organism or nucleic acid positive controls, which are difficult to distinguish from actual positives, especially in low-concentration samples, and require specialized handling and storage of ECMs, making them impractical for many laboratories.
Innovation Solution
Development of engineered positive control sequences that are distinguishable from test amplicons through melt-shifted designs, allowing for clear differentiation and eliminating biological hazards, with room-temperature stability and no special handling required.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If organism or nucleic acid positive controls are used in PCR assays, then assay validation and quality control are improved, but false positive results increase due to contamination
Solution Approach 1:
The patent uses synthetic nucleic acid sequences that copy the structural features of actual pathogen DNA but lack the specific sequence information. These control sequences are designed to amplify with the same primers as test samples but produce distinguishable products through melt-shifted melting temperatures, allowing laboratory validation without creating false positive results from actual pathogen contamination.
Solution Approach 2:
The patent introduces an intermediary substance - synthetic nucleic acid control sequences - that mediates between the need for positive controls and the risk of false positives. These control sequences serve as placeholders that can be amplified and detected without representing actual pathogens, thus eliminating the contamination risk while maintaining validation functionality.
2Reliability
If well-characterized positive clinical specimens or live pathogens are used as ECMs, then assay performance verification is improved, but biological hazards and specialized handling requirements increase
Solution Approach 1:
The patent employs synthetic nucleic acid sequences that can be easily manufactured, stored, and disposed of without biological containment requirements. These control sequences are non-infectious, stable at room temperature, and do not require specialized handling facilities, making them accessible to laboratories without biosafety level 3 or 4 containment capabilities.
Solution Approach 2:
The control sequences are synthetic copies designed to mimic the amplification characteristics of actual pathogens without containing any biological hazard. They replicate the functional aspect of positive controls (amplification with specific primers) while eliminating all biological risk associated with live or inactivated organisms.
3Object-generated harmful factors
If strict protocols with separate facilities for preamplification and amplification are followed, then false positive results are reduced, but operational convenience deteriorates
Solution Approach 1:
The synthetic control sequences act as an intermediary that enables relaxed laboratory protocols. Because these controls cannot cause false positives through contamination, laboratories can perform all steps (sample preparation, amplification, detection) in the same facility without requiring separate biosafety zones, thereby maintaining protocol simplicity while eliminating the need for strict separation.
4Productivity
If multiplex PCR is used to assay multiple targets concurrently, then productivity is improved, but robustness and analysis clarity deteriorate
Solution Approach 1:
The patent applies local quality differentiation by designing control sequences with specific local sequence variations that create distinct melting temperature profiles. Each control sequence is engineered with particular nucleotide compositions that result in characteristic melt patterns, allowing clear differentiation between control and test amplicons even within complex multiplex reactions containing multiple targets.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered control sequences effectively reduce the risk of false positives and simplify ECM preparation, making them suitable for a broader range of laboratories without the need for specialized facilities or handling.
Implementation Method 1
Each positive control sequence has a melting temperature different from its corresponding test sequence
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Systems, methods, and apparatus are provided for external control testing of an assay system.